Northern Trust’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,384
Closed -$213K 4431
2024
Q1
$213K Sell
1,384
-18
-1% -$2.75K ﹤0.01% 3879
2023
Q4
$222K Buy
+1,402
New +$201K ﹤0.01% 3866
2021
Q4
Sell
-1,502
Closed -$249K 4778
2021
Q3
$249K Buy
+1,502
New +$257K ﹤0.01% 4077
2020
Q4
Sell
-1,681
Closed -$265K 4391
2020
Q3
$265K Buy
1,681
+328
+24% +$53.6K ﹤0.01% 3751
2020
Q2
$227K Buy
+1,353
New +$212K ﹤0.01% 3727
2020
Q1
Sell
-1,353
Closed -$201K 4230
2019
Q4
$201K Buy
+1,353
New +$186K ﹤0.01% 3796
2019
Q2
Sell
-1,994
Closed -$301K 4279
2019
Q1
$301K Sell
1,994
-282
-12% -$40.6K ﹤0.01% 3671
2018
Q4
$282K Buy
2,276
+56
+3% +$7.66K ﹤0.01% 3695
2018
Q3
$352K Buy
2,220
+292
+15% +$44.2K ﹤0.01% 3714
2018
Q2
$270K Buy
+1,928
New +$265K ﹤0.01% 3759
2018
Q1
Sell
-1,689
Closed -$210K 4260
2017
Q4
$210K Buy
+1,689
New +$209K ﹤0.01% 3804
2016
Q3
Sell
-2,836
Closed -$254K 4194
2016
Q2
$254K Sell
2,836
-579
-17% -$53.2K ﹤0.01% 3663
2016
Q1
$299K Buy
3,415
+386
+13% +$34K ﹤0.01% 3603
2015
Q4
$342K Sell
3,029
-178
-6% -$19.2K ﹤0.01% 3593
2015
Q3
$325K Sell
3,207
-4
-0.1% -$476 ﹤0.01% 3599
2015
Q2
$398K Buy
3,211
+1,191
+59% +$144K ﹤0.01% 3612
2015
Q1
$239K Buy
+2,020
New +$228K ﹤0.01% 3809
2014
Q4
Sell
-4,289
Closed -$394K 4282
2014
Q3
$394K Hold
4,289
﹤0.01% 3626
2014
Q2
$353K Hold
4,289
﹤0.01% 3695
2014
Q1
$329K Hold
4,289
﹤0.01% 3655
2013
Q4
$297K Buy
+4,289
New +$281K ﹤0.01% 3618

Other funds holding FBT

Northern Trust's FBT Position: Q2 2024 in Review

Northern Trust sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2024, closing a stake of 1,384 shares — an estimated $213K sold.

Northern Trust first reported a position in FBT in Q4 2013 and held it in 21 quarters. The position peaked at $398K in Q2 2015. 251 funds tracked by Wall St. Rank hold FBT as of Q2 2024.

  • Northern Trust reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2024 after selling out during the quarter.
  • Northern Trust sold 1,384 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2024, an estimated $213K.
  • Northern Trust first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2013 and held it in 21 quarters.
  • Northern Trust's First Trust NYSE Arca Biotechnology Index Fund position peaked at $398K in Q2 2015.
  • 251 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2024.

Based on Northern Trust's 13F filing for Q2 2024, filed 14 Aug 2024.